Cardiff Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| COMMODORE CAPITAL LP | 05/15/2025 | 5.38 M | $16.91 M | 0.00% | 8.09% |
| BLACKROCK, INC. | 05/02/2025 | 3.84 M | $12.06 M | 35.24% | 5.78% |
| VANGUARD GROUP INC | 05/09/2025 | 3.12 M | $9.78 M | 36.35% | 4.68% |
| PFIZER INC | 05/13/2025 | 2.41 M | $7.57 B | 0.00% | 3.63% |
| BLAIR WILLIAM & CO/IL | 05/09/2025 | 1.75 M | $5.50 M | 520.96% | 2.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.45 M | $4.54 M | 11.82% | 2.17% |
| 05/19/2025 | 1.44 M | $4.53 M | 0.00% | 2.17% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.39 M | $4.38 M | 41.87% | 2.10% |
| STATE STREET CORP | 05/15/2025 | 940.28 K | $2.95 M | 10.81% | 1.41% |
| MAI CAPITAL MANAGEMENT | 05/15/2025 | 939.59 K | $2.95 M | 2.51% | 1.41% |
| LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 916.21 K | $2.88 M | 58.81% | 1.38% |
| 05/12/2025 | 857.57 K | $2.69 M | 100.00% | 1.29% | |
| CITADEL ADVISORS LLC | 05/15/2025 | 757.84 K | $2.38 M | 992.73% | 1.14% |
| MORGAN STANLEY | 05/15/2025 | 698.53 K | $2.19 M | 28.79% | 1.05% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 664.48 K | $2.09 M | 50.69% | 1.00% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 573.88 K | $1.80 M | -62.70% | 0.86% |
| NORTHERN TRUST CORP | 05/13/2025 | 484.36 K | $1.52 M | 43.69% | 0.73% |
| MARSHALL WACE, LLP | 05/15/2025 | 404.31 K | $1.27 M | 545.86% | 0.61% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 396.12 K | $1.24 M | 183.24% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 378.45 K | $1.19 M | 46.32% | 0.57% |
| GSA CAPITAL PARTNERS LLP | 05/08/2025 | 354.56 K | $1.11 M | -6.71% | 0.53% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 323.35 K | $1.02 M | 12.03% | 0.49% |
| 05/15/2025 | 208.10 K | $653.43 K | 100.00% | 0.31% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 169.97 K | $533.72 K | 67.19% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 168.35 K | $528.62 K | 59.99% | 0.25% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 150.00 K | $471.00 K | 100.00% | 0.23% |
| AVESTAR CAPITAL, LLC | 05/14/2025 | 140.47 K | $441.07 K | 0.00% | 0.21% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 127.97 K | $401.81 K | 100.00% | 0.19% |
| LMR PARTNERS LLP | 05/15/2025 | 125.00 K | $392.50 K | 100.00% | 0.19% |
| SIMPLEX TRADING, LLC | 05/12/2025 | 123.43 K | $387.00 K | 356.08% | 0.19% |
| GOLDMAN SACHS GROUP INC | 05/16/2025 | 107.13 K | $336.40 K | -29.99% | 0.16% |
| CALLAN CAPITAL, LLC | 04/29/2025 | 101.58 K | $318.95 K | 0.00% | 0.15% |
| 05/07/2025 | 96.21 K | $302.09 K | 100.00% | 0.14% | |
| YARBROUGH CAPITAL, LLC | 04/14/2025 | 88.16 K | $276.83 K | 100.00% | 0.13% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 67.23 K | $211.11 K | 0.00% | 0.10% |
| CREATIVE PLANNING | 05/15/2025 | 66.37 K | $208.40 K | 8.86% | 0.10% |
| RHUMBLINE ADVISERS | 05/29/2025 | 63.14 K | $198.26 K | 18.75% | 0.09% |
| BARCLAYS PLC | 05/15/2025 | 61.76 K | $193.00 K | -1.34% | 0.09% |
| CITADEL ADVISORS LLC | 05/15/2025 | 56.30 K | $176.78 K | -37.17% | 0.08% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 55.70 K | $174.89 K | -18.66% | 0.08% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 05/15/2025 | 51.19 K | $160.74 K | 0.00% | 0.08% |
| DEUTSCHE BANK AG\ | 05/09/2025 | 49.44 K | $155.23 K | -0.26% | 0.07% |
| BLACKSTONE INC. | 05/15/2025 | 44.50 K | $139.73 K | 6.71% | 0.07% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 42.24 K | $132.65 K | 31.75% | 0.06% |
| ROYAL BANK OF CANADA | 05/15/2025 | 41.60 K | $130.00 K | -36.85% | 0.06% |
| CITADEL ADVISORS LLC | 05/15/2025 | 41.40 K | $130.00 K | -67.63% | 0.06% |
| CITIGROUP INC | 05/12/2025 | 40.87 K | $128.33 K | 27.83% | 0.06% |
| FMR LLC | 05/12/2025 | 36.16 K | $113.53 K | 1,144.22% | 0.05% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2025 | 35.73 K | $112.18 K | 34.52% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 34.32 K | $107.76 K | 50.38% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cardiff Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 130 institutional investors and hedge funds held shares of Cardiff Oncology, Inc.. The most heavily invested institutionals were:
COMMODORE CAPITAL LP: 5.38 M
BlackRock, Inc.: 3.84 M
VANGUARD GROUP INC: 3.12 M
PFIZER INC: 2.41 M
BLAIR WILLIAM & CO/IL: 1.75 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 1.45 M
48.57% of Cardiff Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 33.68 M shares in the last 24 months. This purchase volume represents approximately $112.48 M in transactions.